Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Crossover Study of the Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Single Doses of HBS 104 in Acutely Sleep-deprived Healthy Participants

NCT07848659 is registered in ClinicalTrials.gov with Harmony Biosciences Management, Inc. as lead sponsor.

NCT NCT07848659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Crossover Study of the Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Single Doses of HBS 104 in Acutely Sleep-deprived Healthy Participants
Lead sponsor
Harmony Biosciences Management, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
August 28, 2026
Completion date
February 18, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep deprivation